Answer:
Phase III
Explanation:
The given condition fall in the trial phase (Phase III) of cinical study which aims to:
- Determine drug's effectiveness (primary goal)
- Determine long-term drug safety
- Confirm findings
In Phase III, randomised, double-blind, placebo-controlled, parallel group study is majorly to evaluate the efficacy and safety of placebo in episodic migraine prevention in children (6 to < 12 years of age) and adolescents (12 to < 18 years of age).
The trial consists of four phases: screening; double-blind therapy period for 24 weeks in which placebo or Erenumab is given to subject as dose 1, dose 2 or dose 3 (based on the participant's body weight) once a month via subcutaneous injection; optional dose level blinded extension phase (40 weeks) which involves subjects recieve dose1, 2 and 3 of placebo, and at last it follows a safety follow-up phase for 12 weeks (after 16 weeks of the last dose of investigational drug).
Hence, the clinical phase is phase III.
As photosynthesis is a process that requires sunlight, the rate of this process will be 0 in a room without any light.
However, even if the dark room has very little light, it may still not be enough for photosynthesis to occur. This process requires certain levels of sunlight.
An example is sexual dimorphism<span>. This refers to differences between the phenotypes of males and females of the same </span>species<span>. In humans, for example, males and females have different heights and body shapes.</span>
The answer is d. 0 n because you pull left 100 n then right 100 n so they will equal back out to 0 n.
